feed,title,long_url,short_url
Benzinga,"Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues",https://benzinga.com/general/biotech/22/02/25359978/novartis-expects-fy22-sales-profit-growth-sandoz-review-continues,https://bit.ly/3upWaGt
